Compounds > pravastatin
Page last updated: 2024-08-23

pravastatin and Angiogenesis, Pathologic

pravastatin has been researched along with Angiogenesis, Pathologic in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Badens, C; Bonello-Palot, N; Bourgeois, P; Dignat-George, F; Levy, N; Robert, S; Sabatier, F; Simoncini, S1
Stefanec, T1
Asakage, M; Kaisaki, S; Kawai, K; Kitayama, J; Nagawa, H; Okaji, Y; Takahashi, K; Tsuno, NH; Yazawa, K1
Filella, X; Franquesa, J; Marcos, JM; Molina, R; Morales, C; Salinas, R; Trapé, J1

Other Studies

4 other study(ies) available for pravastatin and Angiogenesis, Pathologic

ArticleYear
Prelamin A accumulation in endothelial cells induces premature senescence and functional impairment.
    Atherosclerosis, 2014, Volume: 237, Issue:1

    Topics: Atazanavir Sulfate; Cell Adhesion; Cell Proliferation; Cells, Cultured; Cellular Senescence; Diphosphonates; Endothelial Cells; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; Inflammation; Intercellular Adhesion Molecule-1; Lamin Type A; Microscopy, Fluorescence; Monocytes; Neovascularization, Pathologic; Nuclear Proteins; Oligopeptides; Pravastatin; Progeria; Protein Precursors; Pyridines; Umbilical Cord; Umbilical Veins; Zoledronic Acid

2014
The PROSPER trial.
    Lancet (London, England), 2003, Feb-01, Volume: 361, Issue:9355

    Topics: Age Factors; Aged; Aging; Anticholesteremic Agents; Endothelial Growth Factors; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Neoplasms; Neovascularization, Pathologic; Pravastatin; Predictive Value of Tests; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2003
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (pravastatin) inhibits endothelial cell proliferation dependent on G1 cell cycle arrest.
    Anti-cancer drugs, 2004, Volume: 15, Issue:6

    Topics: Angiogenesis Inhibitors; Apoptosis; CDC2-CDC28 Kinases; Cell Division; Cells, Cultured; Cyclin D; Cyclin E; Cyclin-Dependent Kinase 2; Cyclins; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Endothelial Cells; Endothelium, Vascular; Extracellular Matrix; G1 Phase; Gene Expression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neovascularization, Pathologic; Polyisoprenyl Phosphates; Pravastatin; Randomized Controlled Trials as Topic; Sesquiterpenes; Umbilical Veins

2004
Vascular endothelial growth factor serum concentrations in hypercholesterolemic patients.
    Scandinavian journal of clinical and laboratory investigation, 2006, Volume: 66, Issue:3

    Topics: Adult; Aged; Anticholesteremic Agents; Atherosclerosis; C-Reactive Protein; Case-Control Studies; Cholesterol; Cholesterol, LDL; Female; Humans; Hypercholesterolemia; Inflammation Mediators; Male; Middle Aged; Neovascularization, Pathologic; Pravastatin; Triglycerides; Vascular Endothelial Growth Factor A

2006